Results 161 to 170 of about 88,142 (284)

[Withdrawal and reintroduction of pharmacological treatment of epilepsy in paediatric patients. Our experience]. [PDF]

Rev Neurol
Morte-Coscolín P, Gómez-Sánchez C, López-Pisón J, Fariña-Jara MV, Martínez-Calvo FF, Fernando-Martínez R.   +5 more
europepmc   +1 more source

Clinical characteristics of patients with epilepsy attending primary health care. [PDF]

Rev Neurol, 2022
Arteaga-Rodríguez C, Menine-Kubis M, Teixeira-Arteaga CB, Hernández-Fustes OJ.   +3 more
europepmc   +1 more source

The parabss1 Drosophila melanogaster as Model for Chronic Nociception: Insights Into Cannabidiol Analgesic Effects

European Journal of Pain, Volume 30, Issue 2, February 2026.
ABSTRACT Background Chronic pain, which is often unrelated to ongoing injury, is poorly understood and difficult to treat. Genetic studies have identified voltage‐gated sodium (Nav) channels, particularly gain‐of‐function mutations such as L858F and R1150W in human NaV1.7, as involved in the development of chronic pain. Methods A chronic pain model was
Serena Mares Malta, Lucas Ian Veloso Correia, Alexandre Souza Marquez, Lucas Matos Martins Bernardes, John George Howland, Ana Paula Mendes‐Silva, Foued Salmen Espíndola, Carlos Ueira‐Vieira   +7 more
wiley   +1 more source

[Guide to the treatment of paediatric strokes. Iberoamerican Academy of Pediatric Neurology]. [PDF]

Rev Neurol
Buompadre MC, Baltar F, González-Ravellino G, Guerrero GP, Arroyo HA.   +4 more
europepmc   +1 more source

Respuesta a la carta: Neuro-COVID is a serious complication of SARS-CoV-2 infections and can determine the long-term outcome of COVID-19. [PDF]

Rev Panam Salud Publica, 2022
Matar-Khalil S.
europepmc   +1 more source

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.

Journal of Clinical Oncology, 2009
H. Friedman, M. Prados, P. Wen, T. Mikkelsen, D. Schiff, L. Abrey, W. Yung, N. Paleologos, M. Nicholas, R. Jensen, J. Vredenburgh, Jane E. Huang, M. Zheng, T. Cloughesy   +13 more
semanticscholar   +1 more source

Predictors of etiology and drug resistance in children with new‐onset focal seizures

Epilepsia Open, Volume 11, Issue 1, Page 123-135, February 2026.
Abstract Objective To examine the clinical features of new‐onset focal seizures in children and investigate clinical associations and predictors of underlying etiology and drug resistance. Methods Data were gathered from The Children's Hospital at Westmead admissions for patients aged 1 month to 18 years who presented with new‐onset focal seizures ...
Byoung Chan Lee, Russell C. Dale, Elizabeth H. Barnes, Shekeeb S. Mohammad, Sachin Gupta, Chong Wong, Deepak Gill, Kavitha Kothur   +7 more
wiley   +1 more source

[Acute symptomatic epileptic seizures. A clinical-electroencephalographic etiological description and prognosis of an oncopediatric series]. [PDF]

Rev Neurol
Ivarola P, González B, Tedeschini I, Córdoba F, Caraballo R.   +4 more
europepmc   +1 more source

Late‐onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi‐center prospective longitudinal observational study (ELUCID)

Epilepsia Open, Volume 11, Issue 1, Page 363-375, February 2026.
Abstract Objective Late‐onset unexplained epilepsy (LoUE), defined as epilepsy onset after age 55 without an obvious cause, is an important risk factor for dementia. Studies have shown that 10%–25% of individuals with LoUE develop dementia within 3–4 years following their first seizure.
Alice D. Lam, Emily L. Johnson, Rani A. Sarkis, Leah J. Blank, Tyler E. Gaston, Mouhsin M. Shafi, Rodrigo Zepeda, Kyle R. Pellerin, Nathalie Jette, Douglas N. Greve, Lori B. Chibnik, Rebecca E. Amariglio, Gad A. Marshall, M. Brandon Westover   +13 more
wiley   +1 more source

[Landau-Kleffner Syndrome: Current Etiopathogenesis and Management]. [PDF]

Rev Neurol
Méndez-Álvarez AD, Meneses-León KP, Monsalvo-Soler DB, Morales-Segundo AM, Gómez-Virgilio L, López-Toledo G.   +5 more
europepmc   +1 more source